Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Medtronic stock price, quote, forecast and news

MDT
IE00BTN1Y115
A14M2J

Price

90.62
Today +/-
+0.66
Today %
+0.81 %
P

Medtronic stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Medtronic stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Medtronic stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Medtronic stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Medtronic's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Medtronic Stock Price History

DateMedtronic Price
9/9/202490.62 undefined
9/6/202489.89 undefined
9/5/202489.39 undefined
9/4/202491.03 undefined
9/3/202488.96 undefined
8/30/202488.58 undefined
8/29/202488.19 undefined
8/28/202488.33 undefined
8/27/202488.80 undefined
8/26/202489.34 undefined
8/23/202488.35 undefined
8/22/202487.83 undefined
8/21/202487.54 undefined
8/20/202485.38 undefined
8/19/202484.82 undefined
8/16/202484.60 undefined
8/15/202483.65 undefined
8/14/202481.74 undefined
8/13/202482.27 undefined
8/12/202481.19 undefined

Medtronic Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Medtronic, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medtronic from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medtronic’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Medtronic. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Medtronic’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Medtronic’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medtronic’s growth potential.

Medtronic Revenue, EBIT and net profit per share

DateMedtronic RevenueMedtronic EBITMedtronic Net Income
2030e43.24 B undefined0 undefined10.16 B undefined
2029e41.01 B undefined11.4 B undefined9.57 B undefined
2028e39.33 B undefined10.6 B undefined8.76 B undefined
2027e37.28 B undefined9.67 B undefined8.17 B undefined
2026e35.54 B undefined9.33 B undefined7.58 B undefined
2025e33.94 B undefined8.78 B undefined7.07 B undefined
202432.36 B undefined6.12 B undefined3.68 B undefined
202331.23 B undefined6.35 B undefined3.76 B undefined
202231.69 B undefined6.91 B undefined5.04 B undefined
202130.12 B undefined5.4 B undefined3.61 B undefined
202028.91 B undefined5.56 B undefined4.79 B undefined
201930.56 B undefined6.9 B undefined4.63 B undefined
201829.95 B undefined6.66 B undefined3.1 B undefined
201729.71 B undefined5.96 B undefined4.03 B undefined
201628.83 B undefined5.96 B undefined3.54 B undefined
201520.26 B undefined4.77 B undefined2.68 B undefined
201417.01 B undefined4.83 B undefined3.07 B undefined
201316.59 B undefined4.8 B undefined3.47 B undefined
201216.18 B undefined4.49 B undefined3.62 B undefined
201115.51 B undefined4.48 B undefined3.1 B undefined
201015.39 B undefined4.68 B undefined3.1 B undefined
200914.6 B undefined4.18 B undefined2.07 B undefined
200813.52 B undefined3.66 B undefined2.14 B undefined
200712.3 B undefined3.54 B undefined2.8 B undefined
200611.29 B undefined3.54 B undefined2.55 B undefined
200510.06 B undefined3.15 B undefined1.8 B undefined

Medtronic Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (B)DOCUMENTS
1983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
0.370.390.360.40.50.650.770.871.021.181.331.391.742.172.953.424.235.025.556.417.679.0910.0611.2912.313.5214.615.3915.5116.1816.5917.0120.2628.8329.7129.9530.5628.9130.1231.6931.2332.3633.9435.5437.2839.3341.0143.24
-4.05-5.4510.7124.5730.0817.3013.0517.9015.2812.834.7425.2324.6835.5916.2323.6618.5010.6915.4719.5618.5510.6512.308.929.898.025.430.754.362.512.5019.1542.313.040.822.02-5.384.165.21-1.453.644.874.714.905.504.265.43
63.5164.9462.0962.5366.1467.8467.4967.4467.5867.5468.3768.9469.0072.7974.1673.5073.8774.7874.5974.2275.3475.2175.6675.0774.3174.5075.9076.7376.1475.9775.1374.5268.8668.2968.8169.8270.3467.9465.6268.5365.9865.73------
0.240.250.230.250.330.440.520.580.690.80.910.961.21.582.182.523.133.754.144.765.786.837.618.489.1410.0711.0811.8111.8112.312.4612.6713.9519.6920.4420.9121.4919.6419.7621.7220.6121.27000000
0.070.070.050.080.110.130.140.170.210.250.280.330.440.640.911.091.331.611.812.122.472.833.153.543.543.664.184.684.484.494.84.834.775.965.966.666.95.565.46.916.356.128.789.339.6710.611.40
18.3818.7013.1919.1121.1219.9117.6219.9820.1820.9020.8623.9425.0329.2831.0431.8731.3532.1632.6732.9932.1731.1431.3531.3328.7427.0428.6530.3928.9127.7628.9128.4223.5320.6720.0622.2222.5819.2417.9121.8020.3218.9125.8826.2625.9426.9427.80-
0.050.060.040.050.070.090.10.110.130.160.20.230.290.430.580.60.471.081.050.981.61.961.82.552.82.142.073.13.13.623.473.072.683.544.033.14.634.793.615.043.763.687.077.588.178.769.5710.16
-9.26-35.5939.4739.6217.5714.9413.0017.7021.8021.6017.7726.7245.5836.212.06-21.51132.12-3.51-5.9362.6022.44-7.9141.1910.01-23.70-3.1849.71-0.1016.83-4.15-11.60-12.7232.2613.85-22.9449.193.41-24.7039.74-25.42-2.1892.197.237.837.289.176.14
------------------------------------------------
------------------------------------------------
1.041.040.990.940.90.880.930.940.950.950.950.920.920.971.171.181.211.221.231.221.231.231.221.221.161.141.131.111.081.061.031.011.111.431.391.371.361.351.351.351.331.33000000
------------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Medtronic Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Medtronic is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                                   
0.080.120.140.140.110.080.050.070.110.110.160.180.320.510.250.640.380.581.230.531.491.933.396.13.081.611.683.782.439.3511.0714.2419.4812.6313.7111.239.8510.9510.8210.577.968.01
0.090.10.090.120.150.20.210.260.30.330.330.340.410.460.520.791.031.211.231.521.761.992.292.432.743.293.123.343.763.813.733.815.115.565.595.996.224.655.465.5566.13
0000000000000000000000000730000000000000000
0.10.080.070.080.080.110.120.130.140.170.190.210.220.260.280.420.580.690.730.750.940.880.981.181.221.281.431.481.621.81.711.733.463.473.343.583.754.234.314.625.295.22
0.020.010.020.020.020.030.040.050.060.080.10.110.150.170.190.280.460.560.570.680.490.510.760.670.891.071.231.251.341.381.281.432.791.932.242.192.142.211.962.322.432.59
0.280.30.310.350.370.420.420.510.610.70.780.851.111.391.242.142.443.043.763.494.695.317.4210.387.927.327.459.849.1516.3417.7921.2130.8423.624.8722.9821.9722.0322.5523.0621.6821.94
0.10.110.110.110.120.130.150.180.220.260.280.30.330.420.490.630.770.951.181.451.581.711.861.882.062.222.282.422.492.472.492.394.74.844.364.64.685.766.226.276.617.14
0000000000000.110.220.130.140.210.210.680.640.591.461.570.963.22.322.774.636.120.510.550000.690.520.370.480.690.881.611.28
000000000000000000000000000000000000000000
0000000000000.090.090.10.150.260.290.241.061.0311.021.591.432.192.482.562.732.652.672.2928.126.923.4121.7220.5619.0617.7415.614.8413.23
0000.050.050.060.150.140.140.140.140.370.280.390.390.411.111.0714.044.184.244.284.354.337.528.28.399.529.9310.3310.5940.5341.538.5239.5439.9639.8441.9640.541.4340.99
0.030.050.040.020.030.040.040.050.050.080.090.110.040.050.070.180.20.140.190.230.320.40.470.510.570.620.420.250.680.921.011.462.512.88.012.032.163.523.934.684.795.41
0.140.160.150.170.190.220.340.380.410.470.510.780.841.161.171.512.562.663.287.427.728.89.29.2911.5914.8816.1418.2521.5316.4817.0516.7375.8476.0474.9868.4167.7368.6670.5467.9269.2768.05
0.420.460.460.530.560.640.760.891.021.161.291.621.952.562.413.655.015.77.0410.9112.4114.1116.6219.6719.5122.223.5928.0930.6832.8234.8437.94106.6999.6499.8691.3989.6990.6993.0890.9890.9589.98
                                                                                   
222111336666232447571191201211221221211211161141121121101071041021000000000000.13
0.050.050.0200000000000000000000000000000032.2329.5528.1326.5326.1726.3224.5724.5923.13
0.240.290.320.350.380.390.470.60.710.820.871.091.321.841.782.683.774.565.586.497.818.8910.189.1110.9311.7113.2714.8316.0917.4819.0619.9454.4121.723.2724.3826.2728.1328.5930.2530.3930.4
-4-5-8-1451-34-36-34-35-42-6-32-85-83-121-172-188-183-2465150155-62-286-202-307-420-603-589-591-1,198-1,761-2,544-1,592-2,666-3,560-3,577-2,056-3,241-3,106.13
000000000000000000000000000019613097-614-107-69-194-45092-209-258-212
0.290.340.330.350.390.40.470.570.680.80.841.051.341.841.752.653.774.515.516.437.919.0810.459.3810.9811.5413.1814.6315.9717.1118.6719.4453.2352.0650.2150.7250.0950.7451.4352.5551.4850.21
0.030.020.020.040.030.050.050.040.060.070.080.140.080.10.110.120.160.20.210.270.270.350.370.320.280.380.380.420.50.570.620.741.611.711.561.631.9522.112.282.662.41
0.040.040.040.050.060.070.080.090.110.10.120.140.220.260.230.410.560.480.81.050.80.91.611.191.4222.111.892.361.922.262.944.033.784.445.234.894.845.685.375.225.61
0.010.010.010.010.010.020.040.050.040.060.060.110.120.110.070.10.0500.20.150.440.640.920.460.3500.130.240.150.170.10.281.110.680.751.170.80.760.711.011.151.68
0.020.020.030.040.030.050.070.090.090.080.090.060.030.060.10.130.240.320.152.520.392.360.482.440.51.140.512.581.723.270.9100000000000
00000000000.010000.010000000000.010.010.0100001.62.420.997.522.060.842.780.013.740.021.09
0.090.080.10.130.130.190.230.260.290.310.350.440.460.530.520.761.010.991.363.991.94.243.384.412.563.543.155.124.735.933.895.569.177.1714.2610.088.4710.378.5112.399.0510.79
0.010.010.010.010.010.010.010.010.010.010.010.020.010.020.010.060.020.020.010.011.9801.975.495.585.86.256.948.117.369.7410.3233.7530.1125.9223.724.4922.0226.3820.3724.3423.93
0.010.010.010.020.020.020.010.020.020.020.010.020.040.0500.010.030.0200.230.30.410.480.02000.120.090.460.280.340.394.73.732.981.421.281.171.030.880.710.52
0.010.010.010.020.030.030.030.030.030.030.080.090.110.130.130.160.180.160.160.250.320.380.340.370.391.330.891.311.412.142.22.245.836.586.365.375.256.265.574.615.184.33
0.030.040.030.050.050.060.060.060.050.060.10.130.160.190.140.230.230.190.170.492.60.792.795.885.977.137.268.349.989.7812.2812.9444.2840.4235.2630.4931.0129.4532.9725.8730.2328.77
0.130.120.130.180.170.250.290.320.340.370.450.570.610.720.6611.241.181.534.474.55.036.1710.288.5410.6610.4113.4614.7115.7116.1718.553.4647.5849.5340.5739.4839.8241.4838.2639.2839.56
0.420.460.460.530.560.640.760.891.031.161.291.621.952.552.413.655.015.697.0410.9112.414.1116.6219.6719.5122.223.5928.0930.6832.8234.8437.94106.6999.6499.7491.2989.5790.5592.9190.8190.7789.78
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Medtronic provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Medtronic's financial health and stability.

Assets

Medtronic's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Medtronic must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Medtronic after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Medtronic's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (B)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.090.10.110.130.160.20.230.290.430.580.590.471.081.050.981.61.961.82.552.82.142.073.13.13.623.473.072.683.544.023.14.654.813.635.063.78
0.030.050.040.050.060.070.080.110.110.130.170.220.240.30.330.410.440.460.540.580.640.70.770.80.830.820.851.312.822.922.642.662.662.72.712.7
-3-13-2-14-11-11-30-33-1219-3571-15250202110-143105-236-101-17114415314-7-207-926-460-459-919-304-1,315-422-604-226
-0.03-0.01-0.04-0.04-0.060.030.05-0.01-0.01-0.27-0.21-0.37-0.380.32-0.35-0.290.24-0.08-1.5-0.45-0.370.260.24-1.010.020.360.221.56-1.090.14-0.17-1.080.06-0.7-0.89-0.97
00.01000.010.01-0000.050.130.180.010.320.580.150.090.780.530.281.41.260.10.90.150.461.180.720.780.610.381.371.321.381.431.11
0.010.010.010.010.010.010.010.010.010.020.020.030.010.020.040.050.060.060.110.230.260.210.390.290.310.330.390.581.271.131.150.970.640.580.540.61
0.030.040.040.080.070.110.070.130.260.340.270.380.40.340.540.150.490.560.861.030.720.440.570.830.450.540.520.631.381.032.541.560.881.2511.55
0.080.130.110.130.150.290.360.390.50.480.690.461.031.831.592.082.852.822.222.983.493.884.133.744.474.944.964.95.226.884.687.017.236.247.356.04
-35-52-56-65-77-77-60-96-165-205-204-236-342-439-386-380-424-462-1,244-694-606-663-635-501-484-457-396-571-1,046-1,254-1,068-1,134-1,213-1,355-1,368-1,459
-0.06-0.18-0.11-0.07-0.08-0.16-0.26-0.24-0.43-0.07-0.28-1.34-0.38-1.03-4.38-0.25-1.65-1.6-2.87-1.7-2.79-2.74-4.76-1.73-2.66-3.1-3.59-17.062.25-1.575.86-0.77-3.2-2.87-1.66-3.49
-0.03-0.13-0.05-0.01-0-0.09-0.2-0.14-0.270.14-0.07-1.11-0.03-0.59-40.13-1.23-1.14-1.62-1.01-2.18-2.08-4.12-1.23-2.18-2.64-3.2-16.493.29-0.326.930.36-1.99-1.51-0.29-2.03
000000000000000000000000000000000000
0.030.020.010-0.010.01-0.04-0.040.010.07-0.040.070.05-0.152.35-0.18-0.020.095.41-1.840.830.322.540.020.6-0.031.4318.67-5.132.19-7.64-0.87-0.56-0.57-0-0.6
-640139-21-125-37-37-8-42612665-28614894-262-639-177-2,566-708-1,141-343-865-1,055-1,344-980-1,246-1,271-2,339-3,116-1,768-1,885-664-178-2,115-337
-0.050.010.01-0.01-0.06-0.15-0.07-0.16-0.02-0.36-0.130.6-0.43-0.252.17-0.74-1.01-0.491.3-3.01-0.84-0.850.76-2.01-1.88-2.1-0.9215.95-9.54-3.28-11.95-5.43-4.2-4.14-5.34-4.96
00000045-39418340000000-1,07536402400-118-4013-1166016-5014-81-268163-409
-14-16-18-23-29-33-39-47-60-90-102-131-189-240-278-304-351-405-465-504-565-843-907-969-1,021-1,055-1,116-1,337-2,139-2,376-2,494-2,693-2,894-3,120-3,383-3,616
-0.03-0.040.010.040.01-0.020.03-0.010.050.050.29-0.280.220.56-0.621.060.120.640.76-1.74-0.20.210.130.06-0.15-0.250.483.44-1.972.09-1.30.72-0.25-0.550.12-2.17
45.879.95560.874.2214.4296.1290.3335.8277.2488.4219.6683.91,391.81,203.81,697.82,421.22,3629762,2852,8833,2153,4963,2403,9864,4854,5634,3314,1725,6263,6165,8736,0214,8855,9794,580
000000000000000000000000000000000000

Medtronic stock margins

The Medtronic margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medtronic. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medtronic.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Medtronic's sales revenue. A higher gross margin percentage indicates that the Medtronic retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Medtronic's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Medtronic's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medtronic's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medtronic. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medtronic's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Medtronic Margin History

Medtronic Gross marginMedtronic Profit marginMedtronic EBIT marginMedtronic Profit margin
2030e65.73 %0 %23.49 %
2029e65.73 %27.8 %23.33 %
2028e65.73 %26.94 %22.28 %
2027e65.73 %25.94 %21.91 %
2026e65.73 %26.26 %21.32 %
2025e65.73 %25.88 %20.82 %
202465.73 %18.91 %11.36 %
202365.98 %20.32 %12.03 %
202268.53 %21.8 %15.9 %
202165.62 %17.91 %11.97 %
202067.94 %19.24 %16.56 %
201970.34 %22.58 %15.16 %
201869.82 %22.22 %10.36 %
201768.81 %20.06 %13.56 %
201668.29 %20.67 %12.27 %
201568.86 %23.53 %13.2 %
201474.52 %28.42 %18.02 %
201375.13 %28.91 %20.9 %
201275.97 %27.76 %22.35 %
201176.14 %28.91 %19.96 %
201076.73 %30.39 %20.13 %
200975.9 %28.65 %14.18 %
200874.5 %27.04 %15.82 %
200774.31 %28.74 %22.78 %
200675.07 %31.33 %22.56 %
200575.66 %31.35 %17.94 %

Medtronic Stock Sales Revenue, EBIT, Earnings per Share

The Medtronic earnings per share therefore indicates how much revenue Medtronic has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medtronic earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medtronic's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medtronic’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medtronic's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medtronic Revenue, EBIT and net profit per share

DateMedtronic Sales per ShareMedtronic EBIT per shareMedtronic Earnings per Share
2030e33.71 undefined0 undefined7.92 undefined
2029e31.98 undefined0 undefined7.46 undefined
2028e30.67 undefined0 undefined6.83 undefined
2027e29.07 undefined0 undefined6.37 undefined
2026e27.71 undefined0 undefined5.91 undefined
2025e26.46 undefined0 undefined5.51 undefined
202424.33 undefined4.6 undefined2.76 undefined
202323.43 undefined4.76 undefined2.82 undefined
202223.45 undefined5.11 undefined3.73 undefined
202122.24 undefined3.98 undefined2.66 undefined
202021.4 undefined4.12 undefined3.54 undefined
201922.5 undefined5.08 undefined3.41 undefined
201821.9 undefined4.87 undefined2.27 undefined
201721.36 undefined4.28 undefined2.9 undefined
201620.22 undefined4.18 undefined2.48 undefined
201518.27 undefined4.3 undefined2.41 undefined
201416.77 undefined4.77 undefined3.02 undefined
201316.14 undefined4.67 undefined3.37 undefined
201215.27 undefined4.24 undefined3.41 undefined
201114.33 undefined4.14 undefined2.86 undefined
201013.88 undefined4.22 undefined2.79 undefined
200912.97 undefined3.71 undefined1.84 undefined
200811.81 undefined3.19 undefined1.87 undefined
200710.58 undefined3.04 undefined2.41 undefined
20069.28 undefined2.91 undefined2.09 undefined
20058.24 undefined2.58 undefined1.48 undefined

Medtronic business model

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic is one of the most popular companies on Eulerpool.com.

Medtronic SWOT Analysis

Strengths

Medtronic PLC holds a strong position in the medical technology industry, exhibiting several notable strengths:

  • Extensive product portfolio, with a wide range of medical devices and therapies.
  • Established global presence, operating in various countries worldwide.
  • Excellent research and development capabilities, leading to innovative solutions.
  • Strong brand reputation, recognized for quality and reliability.
  • Strong financial performance and stability, allowing for investment in future growth.

Despite its strengths, Medtronic PLC faces certain weaknesses that can hinder its performance:

  • Dependency on regulatory approvals, as the company's products are subject to government regulations.
  • Vulnerability to product recalls or safety concerns due to the nature of healthcare devices.
  • Relatively high prices of certain products, limiting affordability for some customers.

Medtronic PLC has various opportunities to leverage and expand its business:

  • Growing demand for advanced medical devices in emerging markets.
  • Increasing global healthcare expenditure, providing potential for revenue growth.
  • Innovation in healthcare technology, allowing for the development of new products.
  • Potential mergers and acquisitions to expand market share and product offerings.

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Weaknesses

Despite its strengths, Medtronic PLC faces certain weaknesses that can hinder its performance:

  • Dependency on regulatory approvals, as the company's products are subject to government regulations.
  • Vulnerability to product recalls or safety concerns due to the nature of healthcare devices.
  • Relatively high prices of certain products, limiting affordability for some customers.

Medtronic PLC has various opportunities to leverage and expand its business:

  • Growing demand for advanced medical devices in emerging markets.
  • Increasing global healthcare expenditure, providing potential for revenue growth.
  • Innovation in healthcare technology, allowing for the development of new products.
  • Potential mergers and acquisitions to expand market share and product offerings.

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Opportunities

Medtronic PLC has various opportunities to leverage and expand its business:

  • Growing demand for advanced medical devices in emerging markets.
  • Increasing global healthcare expenditure, providing potential for revenue growth.
  • Innovation in healthcare technology, allowing for the development of new products.
  • Potential mergers and acquisitions to expand market share and product offerings.

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Threats

Medtronic PLC faces several threats that may impact its performance and market position:

  • Intense competition from other medical technology companies.
  • Changes in government regulations and healthcare policies affecting market dynamics.
  • Slowdown in global economic conditions leading to reduced healthcare spending.
  • Rapid technological advancements and potential disruption by new entrants.

Medtronic Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Medtronic historical P/E ratio, EBIT, and P/S ratio.

Medtronic shares outstanding

The number of shares was Medtronic in 2023 — This indicates how many shares 1.333 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medtronic earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medtronic's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medtronic’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medtronic's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medtronic Stock splits

In Medtronic's history, there have been no stock splits.

Medtronic dividend history and estimates

In 2023, Medtronic paid a dividend amounting to 2.75 USD. Dividend means that Medtronic distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Medtronic provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Medtronic’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Medtronic's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Medtronic Dividend History

DateMedtronic Dividend
2030e2.14 undefined
2029e2.14 undefined
2028e2.14 undefined
2027e2.13 undefined
2026e2.14 undefined
2025e2.14 undefined
20242.09 undefined
20232.75 undefined
20222.67 undefined
20212.47 undefined
20202.28 undefined
20192.12 undefined
20181.96 undefined
20171.81 undefined
20161.67 undefined
20151.44 undefined
20141.19 undefined
20131.1 undefined
20121.27 undefined
20110.94 undefined
20100.86 undefined
20090.6 undefined
20080.81 undefined
20070.47 undefined
20060.41 undefined
20050.36 undefined

Medtronic dividend payout ratio

In 2023, Medtronic had a payout ratio of 76.28%. The payout ratio indicates the percentage of the company's profits that Medtronic distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Medtronic represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Medtronic could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Medtronic's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Medtronic Payout Ratio History

DateMedtronic Payout ratio
2030e77.54 %
2029e77.54 %
2028e77.16 %
2027e77.93 %
2026e77.52 %
2025e76.03 %
202480.24 %
202376.28 %
202271.58 %
202192.86 %
202064.41 %
201961.99 %
201886.73 %
201762.63 %
201667.34 %
201559.96 %
201439.57 %
201332.64 %
201237.1 %
201132.69 %
201030.94 %
200932.47 %
200843.45 %
200719.5 %
200619.74 %
200524.32 %
Unfortunately, there are currently no price targets and forecasts available for Medtronic.

Medtronic latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20241.21 1.23  (1.64 %)2025 Q1
6/30/20241.46 1.46  (-0.31 %)2024 Q4
3/31/20241.27 1.3  (2.1 %)2024 Q3
12/31/20231.19 1.25  (4.81 %)2024 Q2
9/30/20231.12 1.2  (7.16 %)2024 Q1
6/30/20231.57 1.57  (-0.2 %)2023 Q4
3/31/20231.28 1.3  (1.63 %)2023 Q3
12/31/20221.29 1.3  (0.79 %)2023 Q2
9/30/20221.13 1.13  (-0.19 %)2023 Q1
6/30/20221.58 1.52  (-3.79 %)2022 Q4
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Medtronic stock

Eulerpool World ESG Rating (EESG©)

74/ 100

🌱 Environment

73

👫 Social

85

🏛️ Governance

64

Environment

Scope 1 - Direct Emissions
131,601
Scope 2 - Indirect emissions from purchased energy
125,156
Scope 3 - Indirect emissions within the value chain
445,247
Total CO₂ emissions
256,757
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
❌
Pesticides
—
Palm Oil
❌
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
✅
Environmentally friendly packaging
✅
Hazardous substances
❌
Fuel consumption and efficiency
✅
Water consumption and efficiency
✅

Social

Percentage of female employees51
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies✅
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Medtronic list of shareholders

%
Name
Stocks
Change
Date
9.82204 % The Vanguard Group, Inc.125,966,739429,39012/31/2023
5.59607 % BlackRock Institutional Trust Company, N.A.71,769,0951,575,90612/31/2023
4.74983 % State Street Global Advisors (US)60,916,1291,425,49312/31/2023
2.24877 % Capital Research Global Investors28,840,303-3,288,63812/31/2023
2.13927 % MFS Investment Management27,435,982-3,191,37912/31/2023
2.08403 % Geode Capital Management, L.L.C.26,727,530423,71312/31/2023
1.87228 % Wellington Management Company, LLP24,011,819-414,50612/31/2023
1.39368 % JP Morgan Asset Management17,873,8303,959,39912/31/2023
1.26333 % Morgan Stanley Smith Barney LLC16,202,052348,34112/31/2023
1.16394 % Norges Bank Investment Management (NBIM)14,927,4771,258,98112/31/2023
1
2
3
4
5
...
10

Medtronic Executives and Management Board

Mr. Geoffrey Martha53
Medtronic Executive Chairman of the Board, Chief Executive Officer (since 2011)
Compensation 15.39 M
Mr. Ivan Fong61
Medtronic Executive Vice President, General Counsel, Corporate Secretary
Compensation 11.72 M
Ms. Karen Parkhill57
Medtronic Chief Financial Officer, Executive Vice President
Compensation 6.12 M
Mr. Sean Salmon58
Medtronic Executive Vice President and President - Cardiovascular Portfolio
Compensation 5.36 M
Mr. Robert ten Hoedt62
Medtronic Executive Vice President and President, Global Regions
Compensation 5.05 M
1
2
3
4

Medtronic Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
OSI Systems, Inc. Stock
OSI Systems, Inc.
SupplierCustomer0,890,290,470,180,820,87
Matthews International A Stock
Matthews International A
SupplierCustomer0,880,660,330,040,300,66
Berry Global Group, Inc. Stock
Berry Global Group, Inc.
SupplierCustomer0,850,590,560,010,160,52
Kaman Corporation Stock
Kaman Corporation
SupplierCustomer0,840,590,750,450,100,27
SurModics Stock
SurModics
SupplierCustomer0,830,860,830,260,900,78
Digi International Inc. Stock
Digi International Inc.
SupplierCustomer0,750,140,140,05-0,180,40
Vishay Intertechnology Stock
Vishay Intertechnology
SupplierCustomer0,740,44-0,06-0,080,510,70
Integer Holdings Corporation Stock
Integer Holdings Corporation
SupplierCustomer0,710,770,800,320,900,80
MEDIANA Stock
MEDIANA
SupplierCustomer0,710,650,560,160,12-0,46
National Instruments Stock
National Instruments
SupplierCustomer0,660,790,830,330,440,57
1
2
3
4
5
...
7

Most common questions regarding Medtronic

What values and corporate philosophy does Medtronic represent?

Medtronic PLC represents values of integrity, collaboration, and innovation. With a strong corporate philosophy focused on improving healthcare, Medtronic strives to create medical technologies that benefit patients worldwide. The company's mission is to alleviate pain, restore health, and extend lives through their innovative medical solutions. Medtronic believes in putting patients first and working together with healthcare professionals to develop cutting-edge therapies. They are dedicated to delivering high-quality products and services with utmost transparency and ethical practices. Medtronic's commitment to excellence and patient-centric approach has made it a leading global provider in the medical technology space.

In which countries and regions is Medtronic primarily present?

Medtronic PLC is primarily present in various countries and regions worldwide. Some of the key markets where Medtronic operates include the United States, Europe (including countries like Germany, France, and the United Kingdom), Asia-Pacific (including China, Japan, and Australia), and Latin America. With a widespread global presence, Medtronic leverages its network to deliver innovative medical technologies and therapies to patients and healthcare professionals across different geographies. This multinational presence enables Medtronic PLC to serve a diverse range of markets and collaborate with healthcare partners to improve patient outcomes and enhance the delivery of healthcare services globally.

What significant milestones has the company Medtronic achieved?

Medtronic PLC, a leading medical technology company, has achieved several significant milestones. The company pioneered the development of the first battery-powered wearable external pacemaker in 1957, revolutionizing cardiac healthcare. In 1960, Medtronic introduced the first implantable pacemaker, a remarkable breakthrough in medical devices. Another notable achievement came in 1978 when Medtronic introduced the first insulin pump for diabetes management, improving the lives of millions. Medtronic has also made advancements in minimally invasive surgery with its innovative instruments and techniques. With a strong focus on research and development, Medtronic continues to push boundaries in healthcare technology, enhancing patient outcomes worldwide.

What is the history and background of the company Medtronic?

Medtronic PLC is a renowned global medical technology company headquartered in Dublin, Ireland. It was founded in 1949 by Earl Bakken and Palmer Hermundslie, initially operating as a medical equipment repair shop. Over the years, Medtronic evolved to become a leader in healthcare solutions, focusing on innovative medical devices and therapies. The company specializes in areas such as cardiovascular, diabetes, neurological, and spine care technologies, serving patients in more than 150 countries worldwide. With a rich history of transformative medical breakthroughs, Medtronic's commitment to improving patient outcomes and advancing healthcare is well-recognized in the industry.

Who are the main competitors of Medtronic in the market?

The main competitors of Medtronic PLC in the market are Abbott Laboratories, Boston Scientific Corporation, and Johnson & Johnson.

In which industries is Medtronic primarily active?

Medtronic PLC is primarily active in the healthcare industry.

What is the business model of Medtronic?

The business model of Medtronic PLC primarily focuses on the development, manufacturing, and distribution of medical technology devices and solutions. Medtronic specializes in the fields of cardiac and vascular therapies, minimally invasive therapies, restorative therapies, and diabetes management. The company aims to improve patient outcomes by providing innovative and high-quality products to healthcare professionals worldwide. Medtronic's business model revolves around collaborating with healthcare providers, patients, and other stakeholders to create innovative solutions that address unmet medical needs. Through strategic partnerships and continuous research and development, Medtronic strives to enhance patient care and improve the overall healthcare landscape.

What is the P/E ratio of Medtronic 2024?

The Medtronic P/E ratio is 32.79.

What is the P/S ratio of Medtronic 2024?

The Medtronic P/S ratio is 3.72.

What is the AlleAktien quality score of Medtronic?

The AlleAktien quality score for Medtronic is 5/10.

What is the revenue of Medtronic 2024?

The Medtronic revenue is 32.36 B USD.

How high is the profit of Medtronic 2024?

The Medtronic profit is 3.68 B USD.

What is the business model of Medtronic

Medtronic PLC is a leading company in the medical technology industry and specializes in offering innovative and advanced therapies for a variety of diseases. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie in Minneapolis, USA, and has since grown into a multinational corporation headquartered in Dublin, Ireland. Medtronic's business model is based on four main divisions: Cardiovascular Medicine, Diabetes, Neuromodulation, and Surgery. In the cardiovascular medicine division, the company offers a wide range of products and therapies for cardiovascular diseases and vascular constrictions. These include implantable pacemakers and defibrillators, stents for the treatment of narrowing in the heart arteries, and systems for monitoring heart rhythm. These products are an important part of medical care for people with severe cardiovascular diseases. In the diabetes division, Medtronic offers a range of insulin pumps and sensors that help people with type 1 diabetes or type 2 diabetes control their blood sugar levels. These technologies enable patients to receive more precise and personalized insulin therapy and can prevent serious complications such as gangrene and stroke. Medtronic's neuromodulation division focuses on the development of systems for the treatment of chronic pain, disorders of the nervous system, and neurological diseases. This includes implantable devices such as spinal cord stimulators that send electrical signals to the nervous system and can block pain stimuli. These devices can significantly improve the lives of patients with neuropathic pain or other conditions. Medtronic's surgery division offers products and technologies to support surgeons in complex procedures. These include cutting and coagulation instruments, surgical navigation systems, and products for bone and tissue regeneration. These products help improve patient outcomes and optimize surgical results. Medtronic is also active in various other areas, including respiratory diseases, urology, and infusion systems. The company focuses on creating innovative solutions that improve patient care and increase patients' quality of life. The focus on research and development is an important part of Medtronic's business model and drives continuous innovation in the field of medical technology. Overall, Medtronic is a company that focuses on the development and manufacture of innovative products and services that contribute to improving healthcare worldwide. The various divisions of the company work together in harmony to create innovations that improve the treatment and quality of life for patients.

What is the Medtronic dividend?

Medtronic pays a dividend of 2.67 USD distributed over 4 payouts per year.

How often does Medtronic pay dividends?

Medtronic pays out a dividend 4 times a year.

What is the Medtronic ISIN?

The ISIN of Medtronic is IE00BTN1Y115.

What is the Medtronic WKN?

The WKN of Medtronic is A14M2J.

What is the Medtronic ticker?

The ticker of Medtronic is MDT.

How much dividend does Medtronic pay?

Over the past 12 months, Medtronic paid a dividend of 2.09 USD . This corresponds to a dividend yield of about 2.31 %. For the coming 12 months, Medtronic is expected to pay a dividend of 2.14 USD.

What is the dividend yield of Medtronic?

The current dividend yield of Medtronic is 2.31 %.

When does Medtronic pay dividends?

Medtronic pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Medtronic?

Medtronic paid dividends every year for the past 48 years.

What is the dividend of Medtronic?

For the upcoming 12 months, dividends amounting to 2.14 USD are expected. This corresponds to a dividend yield of 2.36 %.

In which sector is Medtronic located?

Medtronic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medtronic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medtronic from 10/11/2024 amounting to 0.7 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Medtronic pay the last dividend?

The last dividend was paid out on 10/11/2024.

What was the dividend of Medtronic in the year 2023?

In the year 2023, Medtronic distributed 2.75 USD as dividends.

In which currency does Medtronic pay out the dividend?

The dividends of Medtronic are distributed in USD.

All fundamentals about Medtronic

Our stock analysis for Medtronic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medtronic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.